title: Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.
authors.affiliation: University of Colorado Denver Health Sciences Center, Children's Hospital, USA. ivy.dunbar@tchden.org
authors.forename: D Dunbar
authors.initials: DD
authors.lastname: Ivy
authors.forename: Erika Berman
authors.initials: EB
authors.lastname: Rosenzweig
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Lemarié
authors.forename: Monika
authors.initials: M
authors.lastname: Brand
authors.forename: Daniel
authors.initials: D
authors.lastname: Rosenberg
authors.forename: Robyn J
authors.initials: RJ
authors.lastname: Barst
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D002648:Child; D003240:Connective Tissue Diseases / Q000150:complications; D018450:Disease Progression; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D012189:Retrospective Studies; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan